SAN DIEGO, Nov. 14, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the chief in spine know-how innovation, centered on reworking spine surgical procedure with minimally disruptive, procedurally built-in options, at present introduced it should proceed its partnership with the Cervical Backbone Analysis Society (CSRS) as a diamond sponsor and can attend the CSRS 50th Annual Assembly held November 16 to 19 in San Diego.
“The latest launch of our main posterior cervical fusion answer, Reline Cervical, and our annual assembly sponsorship of a preeminent cervical society, CSRS, underscores our shared perception in additional advancing cervical know-how,” stated Chris Barry, chief govt officer at NuVasive. “We look ahead to showcasing our complete, procedurally built-in C360 portfolio, and its preliminary step towards clever surgical procedure with full Pulse compatibility.”
NuVasive will host two workshops on Thursday, November 17 in room Hillcrest CD. From 6:30 to 7:15 a.m. PT, a hands-on workshop, TDR: What are you ready for? Fantasy vs. actuality, that includes Dr. Ali Mesiwala, DISC Sports activities and Backbone Heart, and Dr. Rory Murphy, Barrow Neurological Institute. From 11:30 a.m. to 12:30 p.m. PT, an trade lunch workshop, Approaching cervicothoracic kyphotic deformities—anterior, posterior and 360, that includes Dr. Praveen Mummaneni, UCSF Health, Dr. Rick Sasso, Indiana Backbone Hospital, and Dr. Todd Albert, Hospital for Particular Surgical procedure.
NuVasive sales space #105/204 will characteristic the Firm’s full C360™ portfolio, made up of best-in-class entry instrumentation, implants, biologic supplies, and enabling applied sciences inside Pulse® for the anterior and posterior cervical spine.
About NuVasive NuVasive, Inc. (NASDAQ: NUVA) is the chief in spine know-how innovation, with a mission to rework surgical procedure, advance care, and alter lives. The Firm’s less-invasive, procedurally built-in surgical options are designed to ship reproducible and clinically confirmed outcomes. The Firm’s complete procedural portfolio contains surgical entry devices, spinal implants, fixation techniques, biologics, software program for surgical planning, navigation and imaging options, magnetically adjustable implant techniques for spine and orthopedics, and intraoperative neuromonitoring know-how and repair choices. With greater than $1 billion in internet gross sales, NuVasive operates in additional than 50 nations serving surgeons, hospitals, and sufferers. For extra data, please go to www.nuvasive.com.
Ahead-Wanting Statements NuVasive cautions you that statements included on this information launch that aren’t an outline of historic information are forward-looking statements that contain dangers, uncertainties, assumptions and different elements which, if they don’t materialize or show right, may trigger NuVasive’s outcomes to vary materially from historic outcomes or these expressed or implied by such forward-looking statements. The potential dangers and uncertainties which contribute to the unsure nature of those statements embody, amongst others, dangers related to acceptance of the Firm’s surgical merchandise and procedures by spine surgeons and hospitals, improvement and acceptance of recent merchandise or product enhancements, scientific and statistical verification of the advantages achieved by way of the usage of NuVasive’s merchandise, the Firm’s means to adequately handle stock because it continues to launch new merchandise, its means to recruit and retain administration and key personnel, and the opposite dangers and uncertainties described in NuVasive’s information releases and periodic filings with the Securities and Alternate Fee. NuVasive’s public filings with the Securities and Alternate Fee can be found at www.sec.gov. NuVasive assumes no obligation to replace any forward-looking assertion to replicate occasions or circumstances arising after the date on which it was made.